Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Farber HW, Loscalzo J . Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655–1665.

    Article  CAS  Google Scholar 

  2. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245.

    CAS  Google Scholar 

  3. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A . Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001; 120: 801–808.

    Article  CAS  Google Scholar 

  4. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J . Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol 1999; 60: 130–135.

    Article  CAS  Google Scholar 

  5. Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.

    Article  CAS  Google Scholar 

  6. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999–1007.

    Article  CAS  Google Scholar 

  7. Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G et al. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J Clin Oncol 2005; 23: 5688–5695.

    Article  Google Scholar 

  8. Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N et al. Hybrid cell–gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003; 108: 889–895.

    Article  CAS  Google Scholar 

  9. Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004; 50: 1296–1304.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Cortelezzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cortelezzi, A., Gritti, G., Del Papa, N. et al. Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. Leukemia 22, 646–649 (2008). https://doi.org/10.1038/sj.leu.2404943

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404943

This article is cited by

Search

Quick links